Streetbeat News

Price Targets

DKS

Citigroup analyst Paul Lejuez has maintained a Neutral rating on Dick's Sporting Goods (NYSE:DKS) and raised the price target from $135 to $153.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:27 am

TSHA

Chardan Capital analyst Geulah Livshits has reiterated a 'Buy' rating on Taysha Gene Therapies (NASDAQ:TSHA) and maintained a price target of $5.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 11:26 am

NVTS

Needham analyst Quinn Bolton maintains a Buy rating on Navitas Semiconductor (NASDAQ:NVTS) and raises the price target from $8 to $10.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 11:24 am

CSSE

Needham analyst Laura Martin has reiterated a 'Buy' rating on Chicken Soup for the Soul (NASDAQ:CSSE) but lowered the price target from $3.5 to $1.25.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:23 am

CURI

Needham analyst Laura Martin maintains a Buy rating on CuriosityStream (NASDAQ:CURI) but lowers the price target from $2 to $1.5.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 11:23 am

CMPO

Needham analyst John Todaro has reiterated a 'Buy' rating on CompoSecure (NASDAQ:CMPO) and maintained a price target of $15.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 11:23 am

ZURA

Raymond James analyst Steven Seedhouse maintains a Strong Buy on Zura Bio (NASDAQ:ZURA) and raises the price target from $20 to $22.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 11:20 am

ACLX

Needham analyst Gil Blum has reinstated Arcellx (NASDAQ:ACLX) with a Buy rating and maintained a $51 price target.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:18 am

QDEL

Raymond James analyst Andrew Cooper maintains a Strong Buy on QuidelOrtho (NASDAQ:QDEL) but lowers the price target from $130 to $110.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 11:18 am

GALT

HC Wainwright & Co. analyst Ed Arce has reiterated a 'Buy' rating on Galectin Therapeutics (NASDAQ:GALT) and maintained an $11 price target.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:17 am